Table II.
Treatment information | Total treated (n=36) |
Genotype 1 (n=13) |
Genotype 2 (n=12) |
Genotype 3 (n=11) |
---|---|---|---|---|
SVR †, (%) | 20 (55.6%) | 5 (38.5%) | 7 (58.3%) | 8 (72.7%) |
Relapse/no response (%) | 16 (44.4%) | 8 (61.5%) | 5 (41.6%) | 3 (27.2%) |
SVR †- Sustained viral response